Recombinant CD4 (Clenoliximab Biosimilar) antibody

Catalog No. ABIN7813236

This anti- antibody is a Chimeric Chimeric antibody detecting in . Suitable for Human.

Quick Overview for Recombinant CD4 (Clenoliximab Biosimilar) antibody (ABIN7813236)

Target: CD4 (Clenoliximab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Chimeric

Clonality: Chimeric

Conjugate: Un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details

Expression System: Mammalian cells

Purpose: Clenoliximab Biosimilar - Anti-CD4 mAb - Research Grade

Characteristics: IgG4-lambda

Isotype: IgG4, lambda

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: 0.01M PBS, pH 7.4.

Handling Advice: Avoid repeated freeze-thaw cycles

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: 4°C for short term (1 week), store at -20°C to -80°C for long term(1 year), Avoid repeated freeze-thaw cycles

Expiry Date: 12 months

Target Details

Target: CD4 (Clenoliximab Biosimilar)

Alternative Name: Clenoliximab Biosimilar

Target Type: Biosimilar

Background: Anti-CD4, CE9, 4PE, IDEC-151,

UniProt: P01730

CAS-No: CAS: 182912-58-9